TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
ATE451104T1
(de)
|
2002-07-29 |
2009-12-15 |
Rigel Pharmaceuticals Inc |
Verfahren zur behandlung oder pruvention von autoimmunkrankheiten mit 2,4-pyrimidindiamin- verbindungen
|
UA80767C2
(en)
*
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
PL379330A1
(pl)
|
2002-12-20 |
2006-08-21 |
Pfizer Products Inc. |
Pochodne pirymidyny dla leczenia nienormalnego wzrostu komórek
|
US7109337B2
(en)
|
2002-12-20 |
2006-09-19 |
Pfizer Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
CN1849318B
(zh)
|
2003-07-30 |
2011-10-12 |
里格尔药品股份有限公司 |
用2,4-嘧啶二胺化合物预防和治疗自体免疫疾病的方法
|
SG145749A1
(en)
*
|
2003-08-15 |
2008-09-29 |
Novartis Ag |
2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
|
BRPI0510963A
(pt)
|
2004-05-14 |
2007-11-20 |
Pfizer Prod Inc |
derivados pirimidina para o tratamento do crescimento anormal de células
|
MXPA06013164A
(es)
|
2004-05-14 |
2007-02-13 |
Pfizer Prod Inc |
Derivados de pirimidina para el tratamiento de crecimiento de celulas anormal.
|
WO2005111024A1
(fr)
|
2004-05-14 |
2005-11-24 |
Pfizer Products Inc. |
Derives de pyrimidine destines au traitement de croissance cellulaire anormale
|
WO2006004776A1
(fr)
|
2004-06-29 |
2006-01-12 |
Rigel Pharmaceuticals, Inc. |
Composés de 4-pyrimidineamine et leurs utilisations en tant qu’agent anti-prolifération
|
US20060051406A1
(en)
*
|
2004-07-23 |
2006-03-09 |
Manjeet Parmar |
Formulation of insoluble small molecule therapeutics in lipid-based carriers
|
GB0419160D0
(en)
*
|
2004-08-27 |
2004-09-29 |
Novartis Ag |
Organic compounds
|
GB0419161D0
(en)
*
|
2004-08-27 |
2004-09-29 |
Novartis Ag |
Organic compounds
|
CA2580838A1
(fr)
*
|
2004-09-27 |
2006-04-06 |
Amgen Inc. |
Composes heterocycliques substitues et procedes d'utilisation
|
CA2584295C
(fr)
|
2004-11-24 |
2014-08-26 |
Rigel Pharmaceuticals, Inc. |
Composes de spiro-2, 4-pyrimidinediamine et leurs utilisations
|
BRPI0606318B8
(pt)
|
2005-01-19 |
2021-05-25 |
Rigel Pharmaceuticals Inc |
composto, composição, e, uso de um composto
|
US20060247263A1
(en)
*
|
2005-04-19 |
2006-11-02 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
KR100602320B1
(ko)
*
|
2005-05-03 |
2006-07-18 |
주식회사 하이닉스반도체 |
프로그램 속도가 균일한 비휘발성 메모리 소자
|
US20070203161A1
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
KR101312225B1
(ko)
|
2005-06-08 |
2013-09-26 |
리겔 파마슈티칼스, 인크. |
Jak 경로의 억제를 위한 조성물 및 방법
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
WO2007111720A2
(fr)
|
2005-12-06 |
2007-10-04 |
Rigel Pharmaceuticals, Inc. |
Formulation d'agents thérapeutiques à base de petites molécules insolubles dans des supports lipidiques
|
UA89123C2
(ru)
|
2005-12-21 |
2009-12-25 |
Пфайзер Продактс Инк. |
Производные пиримидина для лечения абнормального роста клеток
|
TW200736232A
(en)
*
|
2006-01-26 |
2007-10-01 |
Astrazeneca Ab |
Pyrimidine derivatives
|
JP2009528295A
(ja)
|
2006-02-24 |
2009-08-06 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Jak経路の阻害のための組成物および方法
|
GB2451594A
(en)
*
|
2006-03-15 |
2009-02-04 |
Csir |
Modulation of phosphoryl transferase activity of glutamine synthetase
|
BRPI0621509A2
(pt)
*
|
2006-03-15 |
2011-12-13 |
Csir |
modulação da atividade de fosforil transferase de glutamina sintetase
|
DE602007012363D1
(de)
|
2006-10-19 |
2011-03-17 |
Rigel Pharmaceuticals Inc |
2,4-pyridimediamon-derivate als hemmer von jak-kinasen zur behandlung von autoimmunerkrankungen
|
EP2684874B1
(fr)
|
2006-10-23 |
2017-05-17 |
Cephalon, Inc. |
Dérivés bicycliques fusionnés de 2,4-diaminopyrimidine utilisés comme inhibiteurs de alk et de c-met
|
KR101364277B1
(ko)
|
2006-12-08 |
2014-02-21 |
아이알엠 엘엘씨 |
단백질 키나제 억제제로서의 화합물
|
EP1939185A1
(fr)
*
|
2006-12-20 |
2008-07-02 |
Bayer Schering Pharma Aktiengesellschaft |
Nouveaux hetaryl-phénylènediamine-pyrimidines en tant qu'inhibiteurs de protéine kinase pour le traitement du cancer
|
MX2009006454A
(es)
|
2006-12-22 |
2009-06-26 |
Hoffmann La Roche |
Derivados de espiro-piperidina.
|
FR2911137B1
(fr)
*
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2,4-dianilinopyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
KR20090129434A
(ko)
*
|
2007-03-01 |
2009-12-16 |
수퍼젠, 인크. |
피리미딘-2,4-디아민 유도체 및 jak2 키나제 억제제로서의 이의 용도
|
EP1969929A1
(fr)
|
2007-03-12 |
2008-09-17 |
Bayer CropScience AG |
Phénylamidine substituée et son utilisation en tant que fongicide
|
AU2014201847B2
(en)
*
|
2007-04-18 |
2015-12-24 |
Pfizer Products Inc. |
Sulfonyl amide derivatives for the treatment of abnormal cell growth
|
AU2016201820B2
(en)
*
|
2007-04-18 |
2018-03-08 |
Pfizer Products Inc. |
Sulfonyl amide derivatives for the treatment of abnormal cell growth
|
WO2008129380A1
(fr)
*
|
2007-04-18 |
2008-10-30 |
Pfizer Products Inc. |
Dérivés de sulfonyle amide pour le traitement d'une croissance cellulaire anormale
|
CA2707653A1
(fr)
*
|
2007-12-03 |
2009-06-11 |
Boehringer Ingelheim International Gmbh |
Nouveaux composes
|
US7923450B2
(en)
|
2008-01-11 |
2011-04-12 |
Hoffmann-La Roche Inc. |
Modulators for amyloid beta
|
MX2010008700A
(es)
*
|
2008-02-22 |
2010-08-30 |
Hoffmann La Roche |
Moduladores de beta-amiloide.
|
US8138339B2
(en)
|
2008-04-16 |
2012-03-20 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
WO2009136995A2
(fr)
|
2008-04-16 |
2009-11-12 |
Portola Pharmaceuticals, Inc. |
Inhibiteurs de la syk protéine kinase
|
NZ589315A
(en)
|
2008-04-16 |
2012-11-30 |
Portola Pharm Inc |
2,6-diamino-pyrimidin-5-yl-carboxamides as Spleen tryosine kinase (syk) or Janus kinase (JAK) inhibitors
|
CA2723185A1
(fr)
|
2008-04-22 |
2009-10-29 |
Portola Pharmaceuticals, Inc. |
Inhibiteurs de proteines kinases
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
DK2300013T3
(en)
|
2008-05-21 |
2017-12-04 |
Ariad Pharma Inc |
PHOSPHORUS DERIVATIVES AS KINASE INHIBITORS
|
DE102008049323A1
(de)
*
|
2008-09-29 |
2010-04-01 |
Henkel Ag & Co. Kgaa |
Neue Entwicklerkomponenten
|
BRPI0920651A2
(pt)
|
2008-10-09 |
2016-01-12 |
Hoffmann La Roche |
moduladores para amiloide beta
|
CN102209537A
(zh)
|
2008-11-10 |
2011-10-05 |
弗·哈夫曼-拉罗切有限公司 |
杂环γ分泌酶调节剂
|
CA2749195C
(fr)
*
|
2009-01-15 |
2017-03-07 |
Rigel Pharmaceuticals, Inc. |
Inhibiteurs de la proteine kinase c et leurs utilisations
|
US8933227B2
(en)
|
2009-08-14 |
2015-01-13 |
Boehringer Ingelheim International Gmbh |
Selective synthesis of functionalized pyrimidines
|
EP2464633A1
(fr)
|
2009-08-14 |
2012-06-20 |
Boehringer Ingelheim International GmbH |
Préparation régiosélective de dérivés de 2-amino-5-trifluorométhylpyrimidine
|
US9180127B2
(en)
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
US8486967B2
(en)
|
2010-02-17 |
2013-07-16 |
Hoffmann-La Roche Inc. |
Heteroaryl substituted piperidines
|
CA2798578C
(fr)
|
2010-05-21 |
2015-12-29 |
Chemilia Ab |
Nouveaux derives de pyrimidine
|
US9102625B2
(en)
|
2010-11-01 |
2015-08-11 |
Portola Pharmaceuticals, Inc. |
Nicotinamides as JAK kinase modulators
|
US8846928B2
(en)
|
2010-11-01 |
2014-09-30 |
Portola Pharmaceuticals, Inc. |
Benzamides and nicotinamides as Syk modulators
|
US20130317029A1
(en)
|
2010-11-01 |
2013-11-28 |
Portola Pharmaceuticals, Inc. |
Oxypyrimidines as syk modulators
|
WO2012060847A1
(fr)
|
2010-11-07 |
2012-05-10 |
Targegen, Inc. |
Compositions et procédés de traitement de la myélofibrose
|
CA2830129C
(fr)
|
2011-03-24 |
2016-07-19 |
Chemilia Ab |
Nouveaux derives de pyrimidine
|
US9249124B2
(en)
|
2011-03-30 |
2016-02-02 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Aurora kinase inhibitors and methods of making and using thereof
|
CN103501612B
(zh)
|
2011-05-04 |
2017-03-29 |
阿里亚德医药股份有限公司 |
抑制表皮生长因子受体导致的癌症中细胞增殖的化合物
|
JP6105578B2
(ja)
|
2011-07-21 |
2017-03-29 |
トレロ ファーマシューティカルズ, インコーポレイテッド |
複素環式プロテインキナーゼ阻害剤
|
EP3569598A1
(fr)
*
|
2011-11-17 |
2019-11-20 |
Dana Farber Cancer Institute, Inc. |
Inhibiteurs de la kinase c-jun-n-terminale (jnk)
|
EP2782579B1
(fr)
|
2011-11-23 |
2019-01-02 |
Portola Pharmaceuticals, Inc. |
Inhibiteurs de de la pyrazine kinase
|
EP2606884A1
(fr)
*
|
2011-12-21 |
2013-06-26 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Inhibiteurs de la voie de signalisation notch et leur utilisation dans le traitement des cancers
|
US20150166591A1
(en)
|
2012-05-05 |
2015-06-18 |
Ariad Pharmaceuticals, Inc. |
Methods and compositions for raf kinase mediated diseases
|
KR101446742B1
(ko)
*
|
2012-08-10 |
2014-10-01 |
한국화학연구원 |
N2,n4-비스(4-(피페라진-1-일)페닐)피리미딘-2,4-디아민 유도체 또는 이의 약학적으로 허용가능한 염 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
|
US9676756B2
(en)
|
2012-10-08 |
2017-06-13 |
Portola Pharmaceuticals, Inc. |
Substituted pyrimidinyl kinase inhibitors
|
WO2014063061A1
(fr)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Petites molécules marquées de façon hydrophobe en tant qu'inducteurs de la dégradation de protéine
|
TR201911151T4
(tr)
*
|
2013-03-14 |
2019-08-21 |
Tolero Pharmaceuticals Inc |
Jak2 ve alk2 inhibitörleri ve bunların kullanım yöntemleri.
|
US9611283B1
(en)
|
2013-04-10 |
2017-04-04 |
Ariad Pharmaceuticals, Inc. |
Methods for inhibiting cell proliferation in ALK-driven cancers
|
ES2676734T3
(es)
|
2013-10-18 |
2018-07-24 |
Syros Pharmaceuticals, Inc. |
Compuestos heteroatómicos útiles para el tratamiento de enfermedades proliferativas
|
AU2014337044A1
(en)
|
2013-10-18 |
2016-05-05 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
|
WO2016022460A1
(fr)
*
|
2014-08-03 |
2016-02-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Puissants doubles inhibiteurs de brd4 et de kinase à utiliser en tant qu'agents thérapeutiques anticancéreux
|
JP6854762B2
(ja)
|
2014-12-23 |
2021-04-07 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
サイクリン依存性キナーゼ7(cdk7)の阻害剤
|
JP6861166B2
(ja)
|
2015-03-27 |
2021-04-21 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
サイクリン依存性キナーゼの阻害剤
|
CA2996978A1
(fr)
|
2015-09-09 |
2017-03-16 |
Dana-Farber Cancer Institute, Inc. |
Inhibiteurs de kinases cycline-dependantes
|
US10738016B2
(en)
|
2015-10-13 |
2020-08-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
BRD4-kinase inhibitors as cancer therapeutics
|
BR112019024830A2
(pt)
*
|
2017-05-26 |
2020-06-09 |
Cancer Research Tech Ltd |
inibidores de bcl6 derivados de benzimidazolona
|
AU2018294054B2
(en)
|
2017-06-30 |
2022-05-26 |
Beijing Tide Pharmaceutical Co., Ltd. |
Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof
|
US10329282B2
(en)
|
2017-06-30 |
2019-06-25 |
Beijing Tide Pharmaceutical Co., Ltd. |
Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof
|
US10323023B2
(en)
|
2017-06-30 |
2019-06-18 |
Beijing Tide Pharmaceutical Co., Ltd. |
Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof
|
CN109776522B
(zh)
*
|
2017-10-30 |
2020-12-29 |
广东东阳光药业有限公司 |
取代的杂芳基化合物及其组合物和用途
|
WO2019195753A1
(fr)
|
2018-04-05 |
2019-10-10 |
Tolero Pharmaceuticals, Inc. |
Inhibiteurs de kinases axl et leur utilisation
|
CA3095580A1
(fr)
|
2018-04-13 |
2019-10-17 |
Sumitomo Dainippon Pharma Oncology, Inc. |
Inhibiteurs de kinase pim pour le traitement de neoplasmes myeloproliferatifs et de fibrose associee au cancer
|
WO2020006724A1
(fr)
*
|
2018-07-05 |
2020-01-09 |
清华大学 |
Composé de dégradation ciblée de protéine fak et utilisation associée
|
KR20210038906A
(ko)
|
2018-07-26 |
2021-04-08 |
스미토모 다이니폰 파마 온콜로지, 인크. |
비정상적 acvr1 발현과 연관된 질환을 치료하는 방법 및 그에 사용하기 위한 acvr1 억제제
|
CN111362922A
(zh)
*
|
2018-12-26 |
2020-07-03 |
上海喆邺生物科技有限公司 |
2,4-二氨基嘧啶衍生物及其用途
|
WO2020167990A1
(fr)
|
2019-02-12 |
2020-08-20 |
Tolero Pharmaceuticals, Inc. |
Formulations comprenant des inhibiteurs de protéine kinase hétérocycliques
|
CN114105887B
(zh)
*
|
2021-09-16 |
2023-12-01 |
沈阳药科大学 |
一种氨基嘧啶衍生物及其制备方法和用途
|